Filing Details
- Accession Number:
- 0001209191-21-046809
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-15 17:53:20
- Reporting Period:
- 2021-07-14
- Accepted Time:
- 2021-07-15 17:53:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595893 | Turning Point Therapeutics Inc. | TPTX | Pharmaceutical Preparations (2834) | 463826166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1758838 | John Andrew Partridge | C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Suite 200 San Diego CA 92121 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-07-14 | 1,869 | $74.90 | 21,767 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares of common stock to cover tax withholding obligations associated with vesting of a restricted stock unit award granted to Reporting Person on July 13, 2020.
Billionaire Hedge Funds
